TC BioPharm to be Delisted from Nasdaq
Ticker: TCBWF · Form: 6-K · Filed: Mar 21, 2025 · CIK: 1872812
| Field | Detail |
|---|---|
| Company | Tc Biopharm (Holdings) PLC (TCBWF) |
| Form Type | 6-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, Nasdaq
TL;DR
Nasdaq is kicking TC BioPharm off the exchange due to non-compliance.
AI Summary
TC BioPharm (Holdings) plc announced on March 21, 2025, that it received notice from the Nasdaq Hearings Panel to delist its securities from The Nasdaq Stock Market LLC. This decision was made because the company failed to comply with Nasdaq's listing requirements.
Why It Matters
The delisting from Nasdaq will significantly impact TC BioPharm's ability to raise capital and trade its shares, potentially affecting its valuation and investor confidence.
Risk Assessment
Risk Level: high — Delisting from a major stock exchange like Nasdaq poses significant risks to a company's liquidity, investor access, and overall financial health.
Key Players & Entities
- TC BioPharm (Holdings) plc (company) — Registrant
- Nasdaq (company) — Stock Exchange
- Nasdaq Hearings Panel (company) — Panel making delisting decision
- March 21, 2025 (date) — Date of press release and notice
FAQ
What is the primary reason for TC BioPharm's delisting from Nasdaq?
TC BioPharm is being delisted because it failed to comply with Nasdaq's listing requirements.
When was the delisting notice issued?
The notice was issued on March 21, 2025.
Which entity made the decision to delist TC BioPharm?
The Nasdaq Hearings Panel made the determination to delist the company's securities.
What is the name of the stock exchange from which TC BioPharm's securities will be delisted?
The securities will be delisted from The Nasdaq Stock Market LLC.
What form is this filing?
This filing is a Form 6-K, a Report of Foreign Private Issuer.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 21, 2025 regarding TC BioPharm (Holdings) plc (TCBWF).